Atlas Trials

Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Clinical trial NCT03138655 · COMPLETED

Trial details

NCT number
NCT03138655
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative ColitisCrohn's Disease
Start date
2017-11-08
Primary completion
2020-03-31
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.